Pacemaker clinic: An opportunity to detect silent atrial fibrillation and improve antithrombotic treatment

Europace

Volumn 13, Issue 11, 2011, Pages 1574-1579

  Cabrera, Sandra ^a   Mercé, Jordi ^a   De Castro, Ramón ^a   Aguirre, Carlos ^a   Carmona, Ana ^a   Pinedo, Mar ^a   Salmerón, Marta ^a   Bardají, Alfredo ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Anticoagulants.; Atrial fibrillation; Embolism; Pacemaker

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; TRIFLUSAL; WARFARIN;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; ELECTROGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HEART ATRIUM PACING; HEART FAILURE; HEART VENTRICLE PACING; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT MONITORING; PRESCRIPTION; PRIORITY JOURNAL; SCORING SYSTEM; SINUS NODE DISEASE; SYNCOPE; THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ATRIAL FLUTTER; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; PACEMAKER, ARTIFICIAL; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM;

EID: 80054914090     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur160     Document Type: Article

References (23)

1. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74:236-41. (Pubitemid 24239044)
2. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997;96: 2455-61. (Pubitemid 27425856)
3. Nielsen JC. Mortality and incidence of atrial fibrillation in paced patients. J Cardiovasc Electrophysiol 2002;13(Suppl. 1):S17-22. (Pubitemid 34112399)
4. Sparks PB, Mond HG, Kalman JM, Jayaprakash S, Lewis MA, Grigg LE. Atrial fibrillation and anticoagulation in patients with permanent pacemakers: Implications for stroke prevention. PACE 1998;21:1258-67. (Pubitemid 28270059)
5. Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R et al. Asymptomatic atrial fibrillation: Demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149:657-63.
6. Savelieva I, Camm AJ. Clinical relevance of silent atrial fibrillation: Prevalence, prognosis, quality of life and management. J Interv Card Electrophysiol 2000;4: 369-82.
7. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57 (correction in Arch Intern Med 1994;154:2254).
8. Stewart S, Hart CL, Hole DJ, Mc Murray JJ. A population-based study of the longterm risks asociated with atrial fibrillation: 20-year follow-up of the Renrew/Pailey study. Am J Med 2002;113:359-64. (Pubitemid 35223606)
9. Fuster V, Rydén LE, Cannom DS, Crijns HI, Curtis AB, Ellenbogen KA et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Europace 2006;8:651-745.
10. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70. (Pubitemid 32537350)
11. Ruiz Ortiz M, Romo E, Mesa D, Delgado M, Anguita M, López Granados A et al. Predicción de eventos embó licos en pacientes con fibrilación auricular no valvular: Evaluación del score CHADS2 en una población mediterránea. Rev Esp Cardiol 2008;61:29-35. (Pubitemid 351573755)
12. Møller M, Arnsboe P. Danish pacemaker and ICD register. Statistics 2000-2001. Odense, Denmark: Department of Cadiology, Odense University Hospital.
13. Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med 2000;342:1385-91. (Pubitemid 30262395)
14. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R et al. The Mode Selection Trial in Sinus-Node Dysfunction. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002;346:1854-62. (Pubitemid 34603029)
15. Carlsson J, Miketic S, Dees G, Haun S, Cuneo A, Tebbe U. Stroke prevention practices in patients with atrial fibrillation and pacemaker therapy: Evidence for under-use of anticoagulation. Europace 2000;2:115-8.
16. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomised trials. Arch Intern Med 1994;154:1449-57.
17. The Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1995;348:633-8.
18. Smulyan H, Mookherjee S, Taub HA, Warner RA. An analysis of symptoms of patients with permanent ventricular pacemakers. J Clin Epidemiol 1992;45:53-9.
19. Patel AM,Westveer DC, Man KC, Stewart JR, Frumin HI. Treatment of underlying atrial fibrillation: Paced rhythm obscures recognition. JACC 2000;36:784-7.
20. Van Walraven C, Hart RG, Singer DE, Laupacis A, Conolly S, Petersen P et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis. JAMA 2002;288:2441-48. (Pubitemid 35340540)
21. Fang MC, Chang Yhylek EM. Advanced age, anticoagulation intensity, and risk for intracranial haemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 2004;141:745-52.
22. Mant J, Hobbs R, Fletcher K, Roalfe A, Fitzmaurice D, Lip GYH et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial. Lancet 2007;370:493-503. (Pubitemid 47212371)
23. Roberts PR. Follow up and optimisation of cardiac pacing. Heart 2005;91: 1229-34. (Pubitemid 41192415)